MMedication Read More FDA sends warning to 30 telehealth companies selling ‘illegal’ GLP-1sMarch 11, 2026 The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales…
MMedication Read More FDA to offer bonus payments to staffers who complete speedy drug reviewsFebruary 28, 2026 WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to…
MMedication Read More FDA will drop two-study requirement for new drug approvals, aiming to speed accessFebruary 19, 2026 WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
MMedication Read More Exclusive-US FDA delays two drug reviews in new voucher program after safety, efficacy concernsJanuary 15, 2026 Jan 15 (Reuters) – The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for…
HHealth care Read More Top FDA drug regulator plans to depart weeks into jobDecember 3, 2025 The nation’s top drug regulator, Richard Pazdur, has decided to retire three weeks after taking the job. Pazdur…
HHealth care Read More The FDA Just Announced A Major Update On Hormone Therapy In The U.S. Here’s What It Means For YouNovember 11, 2025 “Hearst Magazines and Yahoo may earn commission or revenue on some items through these links.” Today, the FDA…
NNews Read More Sarepta Refused FDA’s Request to Halt Elevidys ShipmentsJuly 19, 2025 (Bloomberg) — Sarepta Therapeutics Inc. has refused to pause all shipments of its Elevidys treatment after three deaths…
HHealth Read More FDA requires updated warning about rare heart risk with COVID shotsJune 26, 2025 WASHINGTON (AP) — The Food and Drug Administration said Wednesday it has expanded existing warnings on the two…